Detalhe da pesquisa
1.
Trial of Solanezumab in Preclinical Alzheimer's Disease.
N Engl J Med
; 389(12): 1096-1107, 2023 Sep 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-37458272
2.
Reduced fire severity offers near-term buffer to climate-driven declines in conifer resilience across the western United States.
Proc Natl Acad Sci U S A
; 120(11): e2208120120, 2023 03 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-36877837
3.
Applying climate change refugia to forest management and old-growth restoration.
Glob Chang Biol
; 29(13): 3692-3706, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37029763
4.
Trial of Solanezumab for Mild Dementia Due to Alzheimer's Disease.
N Engl J Med
; 378(4): 321-330, 2018 01 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-29365294
5.
Phase 3 randomized, placebo-controlled, double-blind study of lasmiditan for acute treatment of migraine.
Brain
; 142(7): 1894-1904, 2019 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31132795
6.
Interim results of a prospective, randomized, open-label, Phase 3 study of the long-term safety and efficacy of lasmiditan for acute treatment of migraine (the GLADIATOR study).
Cephalalgia
; 39(11): 1343-1357, 2019 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-31433669
7.
Effect of a rescue or recurrence dose of lasmiditan on efficacy and safety in the acute treatment of migraine: findings from the phase 3 trials (SAMURAI and SPARTAN).
BMC Neurol
; 19(1): 191, 2019 Aug 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-31409292
8.
Integrating mechanistic and empirical model projections to assess climate impacts on tree species distributions in northwestern North America.
Glob Chang Biol
; 23(5): 2005-2015, 2017 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-27859937
9.
Statistical properties of continuous composite scales and implications for drug development.
J Biopharm Stat
; 27(6): 1104-1114, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28402165
10.
Florbetapir F18 PET Amyloid Neuroimaging and Characteristics in Patients With Mild and Moderate Alzheimer Dementia.
Psychosomatics
; 57(2): 208-16, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-26892326
11.
Phase 3 solanezumab trials: Secondary outcomes in mild Alzheimer's disease patients.
Alzheimers Dement
; 12(2): 110-120, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-26238576
12.
Pain Freedom at 2 to 8 Hours With Lasmiditan: A Comparison With Rimegepant and Ubrogepant.
Headache
; 60(8): 1793-1796, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32700321
13.
Florbetapir positron emission tomography and cerebrospinal fluid biomarkers.
Alzheimers Dement
; 11(8): 986-93, 2015 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-25916563
14.
Association between clinical measures and florbetapir F18 PET neuroimaging in mild or moderate Alzheimer's disease dementia.
J Neuropsychiatry Clin Neurosci
; 26(3): 214-20, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-24618911
15.
A pooled analysis of injection site-related adverse events in patients with schizophrenia treated with olanzapine long-acting injection.
BMC Psychiatry
; 14: 7, 2014 Jan 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-24423017
16.
Safety and efficacy of olanzapine in the long-term treatment of Japanese patients with bipolar I disorder, depression: an integrated analysis.
Psychiatry Clin Neurosci
; 68(7): 498-505, 2014 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-24417745
17.
Efficacy and safety of olanzapine for treatment of patients with bipolar depression: Japanese subpopulation analysis of a randomized, double-blind, placebo-controlled study.
BMC Psychiatry
; 13: 138, 2013 May 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-23672672
18.
Randomised, double-blind, placebo-controlled study of olanzapine in patients with bipolar I depression.
Br J Psychiatry
; 201(5): 376-82, 2012 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-22918966
19.
Health-related quality of life as measured by the child health questionnaire in adolescents with bipolar disorder treated with olanzapine.
Compr Psychiatry
; 53(7): 1000-5, 2012 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-22520085
20.
Integrated Alzheimer's Disease Rating Scale: Clinically meaningful change estimates.
Alzheimers Dement (N Y)
; 8(1): e12312, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35676941